Soleno Therapeutics (SLNO) Cash from Investing Activities (QoQ) (2014 - 2026)
Soleno Therapeutics (SLNO) Cash from Investing Activities (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.30% |
| Dec 31, 2025 | -37.09% |
| Sep 30, 2025 | -1,055.31% |
| Jun 30, 2025 | -134.51% |
| Mar 31, 2025 | 256.00% |
| Dec 31, 2024 | 59.48% |
| Sep 30, 2024 | 103.34% |
| Jun 30, 2024 | -4.93% |
| Dec 31, 2021 | -160.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2019 | -76.64% |
| Sep 30, 2019 | 7,450.00% |
| Jun 30, 2019 | 40.00% |
| Mar 31, 2019 | 94.25% |
| Dec 31, 2018 | -3,380.00% |
| Dec 31, 2017 | -89.51% |
| Mar 31, 2017 | 76.02% |
| Dec 31, 2016 | -734.00% |
| Sep 30, 2016 | -100.00% |
| Jun 30, 2016 | 94.74% |